Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RUM | Verdant Minerals (VRM) | 10/01/17 | 14 | 16K | |||
|
|||||||
RUM | Ann: Change of Company Name - VERDANT | 02/12/16 | 1 | 2.6K | |||
|
|||||||
RUM | Ann: Final Director's Interest Notice 3Z D Muller | 30/11/16 | 0 | 1.3K | |||
|
|||||||
RUM | Ann: Change of Director's Interest Notice 3Y J Landels | 28/11/16 | 2 | 2.4K | |||
|
|||||||
RUM | Ann: New Chairman's Address J Whiteside | 28/11/16 | 12 | 8.4K | |||
|
|||||||
RUM | Ann: Results of Meeting Proxy Votes | 24/11/16 | 0 | 1.8K | |||
|
|||||||
RUM | Ann: AGM Presentation by CEO | 24/11/16 | 0 | 1.4K | |||
|
|||||||
RUM | Ann: AGM Chairman's Address 2016 | 24/11/16 | 0 | 1.2K | |||
|
See All Discussions